臺灣核心實作指引(TW Core IG)
0.1.1 - Trial Use

This page is part of the 臺灣核心實作指引(TW Core IG) (v0.1.1: Releases) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

CodeSystem: 臺灣藥品藥理治療分類ATC碼

Official URL: https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw Version: 2022-10-24
Active as of 2014-09-19 Computable Name: TWMedcationATC

Copyright/Legal: 衛生福利部食品藥物管理署

臺灣藥品藥理治療分類ATC碼,參照至https://data.gov.tw/dataset/9119,資料提供單位:衛生福利部食品藥物管理署。
此代碼為WHO ATC(http://www.whocc.no/atc)中未涵蓋之代碼,為符合國內代碼使用,故將未被定義之代碼另外呈現。

因原始資料無代碼版本資訊,故使用其「更新日期」作為版本資訊。

This Code system is referenced in the content logical definition of the following value sets:

  • This CodeSystem is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

This case-sensitive code system https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw defines the following codes:

CodeDisplay
A10BD27 metformin, linagliptin and empagliflozin
A16AB22 avalglucosidase alfa
C03DA05 finerenone
D11AH08 abrocitinib
G04BD14 imidafenacin
H01BA06 argipressin
J05AB04 ribavirin
J05AX11 elvitegravir
J05AX12 dolutegravir
J05AX67 ombitasvir, paritaprevir and ritonavir
J05AX68 elbasvir and grazoprevir
L01FX18 amivantamab
L01XE01 imatinib
L01XE03 erlotinib
L01XE06 dasatinib
L01XE10 everolimus
L01XE11 pazopanib
L01XE31 nintedanib
L01XX14 tretinoin
L01XX17 topotecan
L01XX19 irinotecan
L01XX32 bortezomib
L01XX73 sotorasib
L04AA52 ofatumumab
N05CM21 lemborexant
H01AC08 somatrogon
L01EX22 selpercatinib